Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors: A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis

Virchows Archiv

Volumn 440, Issue 5, 2002, Pages 461-475

  Papotti, M ^a   Bongiovanni, M ^a   Volante, M ^a   Allia E ^a   Landolfi, S ^a   Helboe, L ^b   Schindler, M ^c,d   Cole, S ^c   Bussolati, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b University of Cambridge ^*

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

GEP; Immunohistochemistry; Neuroendocrine tumor; Pancreatic islets; RT PCR; Somatostatin receptors

Indexed keywords

MESSENGER RNA; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOCRINE TUMOR; FEMALE; GASTRINOMA; GASTROINTESTINAL TUMOR; GLUCAGONOMA; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSULINOMA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATOSTATINOMA; TUMOR BIOPSY;

EID: 0036271475     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0609-x     Document Type: Article

References (51)

1. Management of nonfunctioning islet cell carcinomas
2. Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification
3. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer
4. Somatostatin receptor localization of pancreatic endocrine tumors
5. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook
6. Treatment of endocrine gastroenteropancreatic tumors with somatostatin analogues
7. The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit
8. Development of selective antibodies against the human somatostatin receptor subtypes sst1-sst5
9. Internalization of [DOTA degrees,125I-Tyr3] octreotide by somatostatin receptor-positive cells in vitro and in vivo: Implications for somatostatin receptor-targeted radio-guided surgery
10. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors
11. Immunohistochemical localization of somatostatin receptor SST2A in the rat pancreas
12. Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours
13. Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies
14. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors
15. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin
16. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors
17. Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: Quantitative analysis by double-layer immunofluorescence confocal microscopy
18. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: A quantitative double-label immunohistochemical analysis
19. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: Consequences with regard to diagnosis, localization, and therapy
20. Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma
21. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells
22. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours
23. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28
24. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung
25. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid
26. Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours
27. Molecular pharmacology of somatostatin receptor subtypes
28. Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas
29. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors
30. Somatostatin receptors in human endocrine tumors
31. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas
32. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization
33. Immunohistochemical localization of somatostatin receptors sst2A in human tumors
34. Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets
35. Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: Facts and artifacts
36. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
37. SST3-selective potent peptidic somatostatin receptor antagonists
38. Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: Membranous versus intracellular location
39. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: Comparison of mRNA analysis with receptor autoradiography
40. Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord
41. Localization of the somatostatin sst2(a) receptor in human cerebral cortex, hippocampus and cerebellum
42. Somatostatin receptors present knowledge and future directions
43. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype- specific antibodies
44. Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction
45. Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours
46. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: An in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice
47. Post-incubation heating significantly improves tyramide signal amplification
48. Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours
49. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney
50. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase